Susan Washer | President & CEO |
Matthew Feinsod | Interim Chief Medical Officer |
William Sullivan | CFO |
Matthew Luchini | BMO Capital Markets |
James Birchenough | Wells Fargo Securities |
Joseph Pantginis | H.C. Wainwright & Company |
David Nierengarten | Wedbush Securities |
Good morning, and welcome to the AGTC First Quarter Fiscal Year 2019 Financial Results Conference Call. Today's call is being recorded.
Before we get started, I would like to remind everyone that during this conference call, AGTC may make forward-looking statements, including statements about the company's financial results, its future business strategies and operations and its product development and regulatory process -- excuse me, progress. Actual results could differ materially from those discussed in these forward-looking statements due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process and other risks described in the Risk Factors section of AGTC's annual report on Form 10-K for the fiscal year ended June 30, 2018.
For introductions and opening remarks, I'd like to turn the call over to Sue Washer, Chief Executive Officer of AGTC.